China Approves First Commercially Available Brain-Computer Interface China has taken a significant step forward in neurotechnology, granting commercial approval for the country’s first brain-computer interface (BCI) device. Developed by Shanghai-based …
Tag:
Fierce Pharma Asia
-
-
Regulatory Roundup: FDA Investigates adzynma,Otsuka’s Voyxact Approved,and Daiichi Sankyo Wins Patent Battle Table of Contents Regulatory Roundup: FDA Investigates adzynma,Otsuka’s Voyxact Approved,and Daiichi Sankyo Wins Patent Battle FDA Launches Investigation …